← Back to Search

Observational for Breast Cancer

N/A
Recruiting
Led By Komal P. Singh, Ph.D., R.N.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month after chemotherapy treatment completion
Awards & highlights

Study Summary

This study evaluates the relationship between alterations in the GI microbiome and GI inflammation on symptom burden in women with breast cancer receiving chemotherapy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month after chemotherapy treatment completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month after chemotherapy treatment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in GI inflammation
Change in GI microbiome profile
Symptom burden - LFS
+2 more
Secondary outcome measures
Associations between microbial composition functional profiles and symptom severity
Change in metabolite abundance

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo stool and blood sample collection, complete questionnaires, and have their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,744 Total Patients Enrolled
83 Trials studying Breast Cancer
13,912 Patients Enrolled for Breast Cancer
Komal P. Singh, Ph.D., R.N.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
44 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
2024. "Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06238986.
All > Phoenix > Paid Studies Minneapolis
~27 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top